US Patent Issued to Henry Ford Health System on Sept. 1 for "Daclatasvir for use in treating lung and prostate cancer" (Michigan Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,838, issued on Sept. 1, was assigned to Henry Ford Health System (Detroit).

"Daclatasvir for use in treating lung and prostate cancer" was invented by Jagadananda Ghosh (Troy, Mich.) and Jitender Monga (Farmington Hills, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses daclatasvir (DCV) for use in the treatment and/or prevention of cancer, preferably lung cancer and/or prostate cancer, more preferably enzalutamide-resistant prostate cancer."

The patent was filed on June 4, 2021, under Application No. 18/000,756.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/n...